Search

Your search keyword '"Higuera-de-la-Tijera F"' showing total 265 results

Search Constraints

Start Over You searched for: Author "Higuera-de-la-Tijera F" Remove constraint Author: "Higuera-de-la-Tijera F"
265 results on '"Higuera-de-la-Tijera F"'

Search Results

2. Position paper on perioperative management and surgical risk in the patient with cirrhosis

4. Current vision on diagnosis and comprehensive care in hepatic encephalopathy

6. The second Mexican consensus on hepatocellular carcinoma. Part II: Treatment

7. The second Mexican consensus on hepatocellular carcinoma. Part I: Epidemiology and diagnosis

8. Sofosbuvir-velpatasvir in Mexican patients with hepatitis C: A retrospective review

9. Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B

11. Posicionamiento sobre manejo perioperatorio y riesgo quirúrgico en el paciente con cirrosis

12. Cambios en el peso y modificaciones en el estilo de vida implementados durante el confinamiento por la pandemia de COVID-19 se asocian como desencadenantes del desarrollo de síntomas gastrointestinales

13. The Mexican consensus on the treatment of hepatitis C

14. Global multi-stakeholder endorsement of the MAFLD definition

16. Desregulación inmunológica y fisiopatología del consumo de alcohol y la enfermedad hepática alcohólica

17. Visión actual sobre el diagnóstico y los cuidados integrales en la encefalopatía hepática

19. The svr10k study: a real-world data with pangenotypic direct-acting antivirals across multiple diverse regions.

20. Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study

23. Evaluation of IL-12 and CXCL-10 in patients with hepatitis C, non-alcoholic fatty liver disease and liver damage for alcohol consumption

25. Prevalence of fibrosis and steatosis determined by transition elastography and controlled attenuation parameter (fibroscanâ) in diabetic patients

26. MELD Na and MELD 3.0 have the best performance in predicting the risk of death at 28 days in patients with severe alcoholic hepatitis in the Mexican population

34. Short-term efficacy and safety of l-ornithine l-aspartate therapy in patients with cirrhosis and minimal hepatic encephalopathy: a real-life cohort study

36. Left-sided portal hypertension as a complication of chronic pancreatitis in a young patient. A case report

37. Serum determination of MMP-2 and MMP-9 in chronic liver disease according to alcohol consumption, non-alcoholic fatty liver disease and hepatitis C

40. Serum determination of IL-1β and IL-1RA in patients with chronic liver diseases

42. Prevalence of high-risk non-alcoholic steatohepatitis according to the fast® index in a group of diabetic patients

43. MMP-7 is a non-invasive biomarker of chronic liver diseases

44. II Consenso mexicano de carcinoma hepatocelular. Parte II: tratamiento

45. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis

46. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis

Catalog

Books, media, physical & digital resources